Skip to main content

CANCER ENDOMETRIAL Y PANCREATICO EN SINDROME DE LYNCH: RETOS MAS ALLA DEL RIESGO DE CANCER COLORECTAL

PID2023-151585OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2023
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACIO INSTITUT D INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Altered chromatin landscape and 3D interactions associated with primary constitutional MLH1 epimutations

  • Climent-Cantó, Paula
  • Subirana-Granés, Marc
  • Ramos-Rodríguez, Mireia
  • Dámaso, Estela
  • Marín, Fátima
  • Vara, Covadonga
  • Pérez-González, Beatriz
  • Raurell Vila, Helena
  • Munté, Elisabet
  • Soto, José Luis
  • Alonso, Ángel
  • Shin, GiWon
  • Ji, Hanlee
  • Hitchins, Megan
  • Capellá, Gabriel
  • Pasquali, Lorenzo
  • Pineda, Marta
Background: Lynch syndrome (LS), characterised by an increased risk for cancer, is mainly caused by germline pathogenic variants affecting a mismatch repair gene (MLH1, MSH2, MSH6, PMS2). Occasionally, LS may be caused by constitutional MLH1 epimutation (CME) characterised by soma-wide methylation of one allele of the MLH1 promoter. Most of these are "primary" epimutations, arising de novo without any apparent underlying cis-genetic cause, and are reversible between generations. We aimed to characterise genetic and gene regulatory changes associated with primary CME to elucidate possible underlying molecular mechanisms. Methods: Four carriers of a primary CME and three non-methylated relatives carrying the same genetic haplotype were included. Genetic alterations were sought using linked-read WGS in blood DNA. Transcriptome (RNA-seq), chromatin landscape (ATAC-seq, H3K27ac CUT&Tag) and 3D chromatin interactions (UMI-4C) were studied in lymphoblastoid cell lines. The MLH1 promoter SNP (c.-93G > A, rs1800734) was used as a reporter in heterozygotes to assess allele-specific chromatin conformation states. Results: MLH1 epimutant alleles presented a closed chromatin conformation and decreased levels of H3K27ac, as compared to the unmethylated allele. Moreover, the epimutant MLH1 promoter exhibited differential 3D chromatin contacts, including lost and gained interactions with distal regulatory elements. Of note, rare genetic alterations potentially affecting transcription factor binding sites were found in the promoter-contacting region of CME carriers. Conclusions: Primary CMEs present allele-specific differential interaction patterns with neighbouring genes and regulatory elements. The role of the identified cis-regulatory regions in the molecular mechanism underlying the origin and maintenance of CME requires further investigation., This study was supported by the National Institute of Health/National Cancer Institute (R01CA218342), the Spanish Ministry of Science and Innovation, which is part of Agencia Estatal de Investigación (AEI), through the Retos Investigación grants (SAF2015-68016-R, PID2019-111254RB-I00, PID2020-117099RB-I00, PID2023-151585OB-I00, and SAF2017-86242-R), CIBERONC (CB16/12/00234), and the Secretariat for Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya grant to support the activities of research groups (2021 SGR 01112). We also thank the CERCA Program/Generalitat de Catalunya for institutional support. M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Altered chromatin landscape and 3D interactions associated with primary constitutional MLH1 epimutations

  • Climent-Cantó, Paula
  • Subirana-Granés, Marc
  • Ramos-Rodríguez, Mireia
  • Dámaso, Estela
  • Marín, Fátima
  • Vara, Covadonga
  • Pérez-González, Beatriz
  • Raurell Vila, Helena
  • Munté, Elisabet
  • Soto, José Luis
  • Alonso, Ángel
  • Shin, GiWon
  • Ji, Hanlee
  • Hitchins, Megan
  • Capellá, Gabriel
  • Pasquali, Lorenzo
  • Pineda, Marta
Background: Lynch syndrome (LS), characterised by an increased risk for cancer, is mainly caused by germline pathogenic variants affecting a mismatch repair gene (MLH1, MSH2, MSH6, PMS2). Occasionally, LS may be caused by constitutional MLH1 epimutation (CME) characterised by soma-wide methylation of one allele of the MLH1 promoter. Most of these are "primary" epimutations, arising de novo without any apparent underlying cis-genetic cause, and are reversible between generations. We aimed to characterise genetic and gene regulatory changes associated with primary CME to elucidate possible underlying molecular mechanisms. Methods: Four carriers of a primary CME and three non-methylated relatives carrying the same genetic haplotype were included. Genetic alterations were sought using linked-read WGS in blood DNA. Transcriptome (RNA-seq), chromatin landscape (ATAC-seq, H3K27ac CUT&Tag) and 3D chromatin interactions (UMI-4C) were studied in lymphoblastoid cell lines. The MLH1 promoter SNP (c.-93G > A, rs1800734) was used as a reporter in heterozygotes to assess allele-specific chromatin conformation states. Results: MLH1 epimutant alleles presented a closed chromatin conformation and decreased levels of H3K27ac, as compared to the unmethylated allele. Moreover, the epimutant MLH1 promoter exhibited differential 3D chromatin contacts, including lost and gained interactions with distal regulatory elements. Of note, rare genetic alterations potentially affecting transcription factor binding sites were found in the promoter-contacting region of CME carriers. Conclusions: Primary CMEs present allele-specific differential interaction patterns with neighbouring genes and regulatory elements. The role of the identified cis-regulatory regions in the molecular mechanism underlying the origin and maintenance of CME requires further investigation., This study was supported by the National Institute of Health/National Cancer Institute (R01CA218342), the Spanish Ministry of Science and Innovation, which is part of Agencia Estatal de Investigación (AEI), through the Retos Investigación grants (SAF2015-68016-R, PID2019-111254RB-I00, PID2020-117099RB-I00, PID2023-151585OB-I00, and SAF2017-86242-R), CIBERONC (CB16/12/00234), and the Secretariat for Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya grant to support the activities of research groups (2021 SGR 01112). We also thank the CERCA Program/Generalitat de Catalunya for institutional support. M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Altered chromatin landscape and 3D interactions associated with primary constitutional MLH1 epimutations

  • Climent-Cantó, Paula
  • Subirana Granés, Marc
  • Ramos-Rodríguez, Mireia
  • Dámaso, Estela
  • Marín, Fátima
  • Vara, Covadonga
  • Pérez-González, Beatriz
  • Raurell, Helena
  • Munté, Elisabeth
  • Soto, José Luis
  • Alonso Sánchez, Ángel Miguel
  • Shin, GiWon
  • Ji, Hanlee
  • Hitchins, Megan
  • Capellá, Gabriel
  • Pasquali, Lorenzo
  • Pineda, Marta
Background: Lynch syndrome (LS), characterised by an increased risk for cancer, is mainly caused by germline pathogenic variants affecting a mismatch repair gene (MLH1, MSH2, MSH6, PMS2). Occasionally, LS may be caused by constitutional MLH1 epimutation (CME) characterised by soma-wide methylation of one allele of the MLH1 promoter. Most of these are "primary" epimutations, arising de novo without any apparent underlying cis-genetic cause, and are reversible between generations. We aimed to characterise genetic and gene regulatory changes associated with primary CME to elucidate possible underlying molecular mechanisms. Methods: Four carriers of a primary CME and three non-methylated relatives carrying the same genetic haplotype were included. Genetic alterations were sought using linked-read WGS in blood DNA. Transcriptome (RNA-seq), chromatin landscape (ATAC-seq, H3K27ac CUT&Tag) and 3D chromatin interactions (UMI-4C) were studied in lymphoblastoid cell lines. The MLH1 promoter SNP (c.-93G > A, rs1800734) was used as a reporter in heterozygotes to assess allele-specific chromatin conformation states. Results: MLH1 epimutant alleles presented a closed chromatin conformation and decreased levels of H3K27ac, as compared to the unmethylated allele. Moreover, the epimutant MLH1 promoter exhibited differential 3D chromatin contacts, including lost and gained interactions with distal regulatory elements. Of note, rare genetic alterations potentially affecting transcription factor binding sites were found in the promoter-contacting region of CME carriers. Conclusions: Primary CMEs present allele-specific differential interaction patterns with neighbouring genes and regulatory elements. The role of the identified cis-regulatory regions in the molecular mechanism underlying the origin and maintenance of CME requires further investigation., This study was supported by the National Institute of Health/National Cancer Institute (R01CA218342), the Spanish Ministry of Science and Innovation, which is part of Agencia Estatal de Investigación (AEI), through the Retos Investigación grants (SAF2015-68016-R, PID2019-111254RB-I00, PID2020-117099RB-I00, PID2023-151585OB-I00, and SAF2017-86242-R), CIBERONC (CB16/12/00234), and the Secretariat for Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya grant to support the activities of research groups (2021 SGR 01112). M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award.